Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Editas Medicine (EDIT) Return on Assets (2016 - 2025)

Editas Medicine (EDIT) has disclosed Return on Assets for 10 consecutive years, with 0.96% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Assets fell 37.0% to 0.96% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.96%, a 37.0% decrease, with the full-year FY2024 number at 0.56%, down 26.0% from a year prior.
  • Return on Assets was 0.96% for Q3 2025 at Editas Medicine, up from 0.99% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.21% in Q1 2021 to a low of 0.99% in Q2 2025.
  • A 5-year average of 0.46% and a median of 0.37% in 2023 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: rose 12bps in 2023, then tumbled -52bps in 2025.
  • Editas Medicine's Return on Assets stood at 0.28% in 2021, then crashed by -53bps to 0.42% in 2022, then grew by 28bps to 0.3% in 2023, then tumbled by -135bps to 0.71% in 2024, then plummeted by -35bps to 0.96% in 2025.
  • Per Business Quant, the three most recent readings for EDIT's Return on Assets are 0.96% (Q3 2025), 0.99% (Q2 2025), and 0.83% (Q1 2025).